stockportfolio.pro
Embecta Corp. (EMBC)
Healthcare · Medical Instruments & Supplies · NasdaqGS
Embecta Corp. revenue & earnings — last 6 fiscal years
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $1.09B | $1.17B | $1.13B | $1.12B | $1.12B | $1.08B |
| Gross profit | $762.60M | $800.40M | $774.90M | $749.90M | $735.20M | $676.80M |
| Net income | $427.60M | $414.80M | $223.60M | $70.40M | $78.30M | $95.40M |
| Net margin | 39.4% | 35.6% | 19.8% | 6.3% | 7.0% | 8.8% |
Source: Embecta Corp. SEC filings (10-K).
Explore 6 years of Embecta Corp. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track EMBC in your portfolio →
About Embecta Corp.
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Embecta Corp. — frequently asked questions
What is Embecta Corp.'s revenue?
Embecta Corp. (EMBC) reported revenue of $1.08B for fiscal year 2025, down 3.9% from the prior year, according to its SEC filings.
Is Embecta Corp. profitable?
Yes. EMBC earned net income of $95.40M in fiscal 2025, a net margin of 8.8%.
What is EMBC's P/E ratio?
Embecta Corp. trades at a price-to-earnings ratio of about 1.7 based on the latest data in our nightly-refreshed cache.
How fast is Embecta Corp. growing?
EMBC's revenue grew at roughly -0.1% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
Where does this data come from?
All figures are computed from Embecta Corp.'s official SEC filings (10-K and 10-Q), covering 6 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.